this policy , which prevents many travellers and overseas residents from benefitting from one of the most effective prophylactic treatments on the market today , thereby indirectly causing a number of pernicious cases of malaria , is based on the unfounded , unproved premise that wide use of this drug would foster the development of mefloquine-resistance or on side-effects , which are in fact rarely of any consequence and always curable .
C0024535
pernicious
C0025153
mefloquine